The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,568
Self-citationProgress and problems with the use of viral vectors for gene therapy
Thomas, C. E., Ehrhardt, A., & Kay, M. A. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1066 · Cited by 2,501
Lawson, N. D., Vogel, A. M., & Weinstein, B. M. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00198-3 · Cited by 813
Zebrafish: a model system for the study of human disease
Dooley, K. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00074-5 · Cited by 745
The art and design of genetic screens: Drosophila melanogaster
St Johnston, D. (2002) · Nature Reviews Genetics · doi:10.1038/nrg751 · Cited by 644
Gridlock signalling pathway fashions the first embryonic artery
Zhong, T. P., Childs, S., Leu, J. P., & Fishman, M. C. (2001) · Nature · doi:10.1038/35102599 · Cited by 553
Self-citationDrugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish
Milan, D. J., Peterson, T. A., Ruskin, J. N., Peterson, R. T., & MacRae, C. A. (2003) · Circulation · doi:10.1161/01.cir.0000061912.88753.87 · Cited by 440
Self-citationgridlock , an HLH Gene Required for Assembly of the Aorta in Zebrafish
Zhong, T. P., Rosenberg, M., Mohideen, M.-A. P. K., Weinstein, B., & Fishman, M. C. (2000) · Science · doi:10.1126/science.287.5459.1820 · Cited by 422
Self-citation
Cited by
Animal models of human disease: zebrafish swim into view
Lieschke, G. J., & Currie, P. D. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2091 · Cited by 2,167
Targeting virulence: a new paradigm for antimicrobial therapy
Clatworthy, A. E., Pierson, E., & Hung, D. T. (2007) · Nature Chemical Biology · doi:10.1038/nchembio.2007.24 · Cited by 1,406
In vivo drug discovery in the zebrafish
Zon, L. I., & Peterson, R. T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1606 · Cited by 1,353
Self-citationZebrafish as tools for drug discovery
MacRae, C. A., & Peterson, R. T. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4627 · Cited by 1,204
Self-citationSträhle, U., Scholz, S., Geisler, R., Greiner, P., Hollert, H., Rastegar, S., Schumacher, A., Selderslaghs, I., Weiss, C., Witters, H., et al. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2011.06.121 · Cited by 673
tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors
Berghmans, S., Murphey, R. D., Wienholds, E., Neuberg, D., Kutok, J. L., Fletcher, C. D. M., Morris, J. P., Liu, T. X., Schulte-Merker, S., Kanki, J. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406252102 · Cited by 597
Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials
Patton, E. E., Zon, L. I., & Langenau, D. M. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00210-8 · Cited by 567
Arterial–Venous Specification During Development
Swift, M. R., & Weinstein, B. M. (2009) · Circulation Research · doi:10.1161/circresaha.108.188805 · Cited by 420
A high-resolution mRNA expression time course of embryonic development in zebrafish
White, R. J., Collins, J. E., Sealy, I. M., Wali, N., Dooley, C. M., Digby, Z., Stemple, D. L., Murphy, D. N., Billis, K., Hourlier, T., et al. (2017) · eLife · doi:10.7554/elife.30860 · Cited by 361
Nidhi, Glick, M., Davies, J. W., & Jenkins, J. L. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci060003g · Cited by 340
Little Fish, Big Data: Zebrafish as a Model for Cardiovascular and Metabolic Disease
Gut, P., Reischauer, S., Stainier, D. Y. R., & Arnaout, R. (2017) · Physiological Reviews · doi:10.1152/physrev.00038.2016 · Cited by 333
Swaim, L. E., Connolly, L. E., Volkman, H. E., Humbert, O., Born, D. E., & Ramakrishnan, L. (2006) · Infection and Immunity · doi:10.1128/iai.00887-06 · Cited by 328
Immunology and zebrafish: Spawning new models of human disease
Meeker, N. D., & Trede, N. S. (2008) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2007.11.011 · Cited by 311
Zebrafish as a pharmacological tool: the how, why and when
Goldsmith, P. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.04.005 · Cited by 304
Walsh, D. P., & Chang, Y.-T. (2006) · Chemical Reviews · doi:10.1021/cr0404141 · Cited by 296
Arterial versus venous endothelial cells
dela Paz, N. G., & D’Amore, P. A. (2009) · Cell and Tissue Research · doi:10.1007/s00441-008-0706-5 · Cited by 293
Zebrafish embryos as models for embryotoxic and teratological effects of chemicals
Yang, L., Ho, N. Y., Alshut, R., Legradi, J., Weiss, C., Reischl, M., Mikut, R., Liebel, U., Müller, F., & Strähle, U. (2009) · Reproductive Toxicology · doi:10.1016/j.reprotox.2009.04.013 · Cited by 283
Vascular Development in the Zebrafish
Gore, A. V., Monzo, K., Cha, Y. R., Pan, W., & Weinstein, B. M. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006684 · Cited by 282
Zebrafish: A Complete Animal Model for In Vivo Drug Discovery and Development
Chakraborty, C., Hsu, C., Wen, Z., Lin, C., & Agoramoorthy, G. (2009) · Current Drug Metabolism · doi:10.2174/138920009787522197 · Cited by 279
Synchrony Dynamics During Initiation, Failure, and Rescue of the Segmentation Clock
Riedel-Kruse, I. H., Müller, C., & Oates, A. C. (2007) · Science · doi:10.1126/science.1142538 · Cited by 268
15 years of zebrafish chemical screening
Rennekamp, A. J., & Peterson, R. T. (2015) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.10.025 · Cited by 264
Self-citationLangenau, D. M., Feng, H., Berghmans, S., Kanki, J. P., Kutok, J. L., & Look, A. T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408708102 · Cited by 261
Repurposing drugs to treat cardiovascular disease in the era of precision medicine
Abdelsayed, M., Kort, E. J., Jovinge, S., & Mercola, M. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00717-6 · Cited by 93
“The advantage of using zebrafish is that they model the complexity of disease in the context of the whole organism, but can still be used for moderate-throughput screening, exemplified by chemical screens that identified compounds that could rescue developmental cardiac defects 88,89 .”
Background
Metadata
- Authors
- Peterson, R. T., Shaw, S. Y., Peterson, T. A., Milan, D. J., Zhong, T. P., Schreiber, S. L., MacRae, C. A., & Fishman, M. C.
- Venue
- Nature Biotechnology
- Published
- 2004-04-18
- Volume
- 22
- Issue
- 5
- Pages
- 595-599
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2034265209
- Cited by
- 384
- References
- 29
- FWCI
- 10.33
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.